Viyash Scientific Ltd.

₹257

- 3.90 (-1.49%)

04:01 pm - close price

BSE: VIYASH

NSE: VIYASH

Industry: Pharmaceuticals & Drugs

House: Sequent

Overview

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Ratios

Reported EPS

Bad: 2Current: 4.06Good: 5

🟡

Adjusted EPS

Bad: 3Current: 4.06Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 13.10Good: 20

🟡

Current Ratio

Bad: 1Current: 2.38Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 9.06Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 9.59Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 4.06Good: 5

🟡

Adjusted EPS

Bad: 3Current: 4.06Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 13.10Good: 20

🟡

Current Ratio

Bad: 1Current: 2.38Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 9.06Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 9.59Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	345.97	329.36	361.20	390.21
Expenditure+	330.84	307.11	328.93	348.26
Other Income+	1.65	4.52	4.00	2.68
Operating Profit	15.13	22.25	32.27	41.95
Interest	12.58	12.58	12.44	16.38
Depreciation and Amortization	15.36	15.46	16.48	16.25
Profit Before Tax	-3.09	1.49	2.64	12.00
Tax+	3.79	-9.18	1.36	2.94
Net Profit	-6.88	10.68	1.27	9.06

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	14128.16	14209.09	13697.31	30068.42	34203.06
Operational Expenses+	13034.31	14089.54	13083.17	26228.40	27677.77
Operating Profit	1093.85	119.55	614.14	3840.02	6525.29
Other Income	108.60	63.90	109.57	358.20	435.54
OPM %	7.74	0.84	4.48	12.77	19.08
Depreciation and Amortisation	515.41	556.93	615.40	2387.12	2336.44
Interest	157.74	355.17	480.86	863.66	692.07
Profit Before Tax	529.30	-1376.58	-546.46	131.81	3490.25
Tax	201.96	-153.57	-244.99	-26.40	1243.74
Net Profit	409.55	-1211.59	-358.69	232.19	1772.85

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	14865.68	14837.61	15310.53	40198.24	45450.22
Liabilities+	14865.68	14837.61	15310.53	40198.24	45450.22

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	305.95	168.08	305.95	3447.99	3229.13
Cash from Investing Activity	-955.66	-649.58	-59.20	-4472.15	-841.18
Cash from Financing Activity	672.57	322.28	-14.39	870.35	-1233.34
Net Cash Flow	22.86	-159.22	232.36	-153.81	1154.61
Opening Cash & Cash Equivalents	537.44	574.96	415.74	1561.79	1402.96
Closing Cash & Cash Equivalents	574.96	415.74	648.10	1402.96	2557.57

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	61.31	61.31	61.41	52.33	52.61	52.61	52.61	52.76	52.78	52.79
Public+	38.69	38.69	38.59	47.67	47.39	47.39	47.39	47.24	47.22	47.21
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	128367	127446	134194	144085	147320	158152	162574	154603	163693	166593

Corporate Actions

253 events in the last 3 years

Cash Flow Statement

In Rs. Cr.	202203	202303	202403	202503	202603
Cash from Operating Activity+	305.95	168.08	305.95	3447.99	3229.13
Cash from Investing Activity	-955.66	-649.58	-59.20	-4472.15	-841.18
Cash from Financing Activity	672.57	322.28	-14.39	870.35	-1233.34
Net Cash Flow	22.86	-159.22	232.36	-153.81	1154.61
Opening Cash & Cash Equivalents	537.44	574.96	415.74	1561.79	1402.96
Closing Cash & Cash Equivalents	574.96	415.74	648.10	1402.96	2557.57

Quarterly Results

In Rs. Cr.	2023-09	2023-12	2024-03	2024-06
Net Sales	345.97	329.36	361.20	390.21
Expenditure+	330.84	307.11	328.93	348.26
Other Income+	1.65	4.52	4.00	2.68
Operating Profit	15.13	22.25	32.27	41.95
Interest	12.58	12.58	12.44	16.38
Depreciation and Amortization	15.36	15.46	16.48	16.25
Profit Before Tax	-3.09	1.49	2.64	12.00
Tax+	3.79	-9.18	1.36	2.94
Net Profit	-6.88	10.68	1.27	9.06

Profit & Loss

In Rs. Cr.	202203	202303	202403	202503	202603
Sales	14128.16	14209.09	13697.31	30068.42	34203.06
Operational Expenses+	13034.31	14089.54	13083.17	26228.40	27677.77
Operating Profit	1093.85	119.55	614.14	3840.02	6525.29
Other Income	108.60	63.90	109.57	358.20	435.54
OPM %	7.74	0.84	4.48	12.77	19.08
Depreciation and Amortisation	515.41	556.93	615.40	2387.12	2336.44
Interest	157.74	355.17	480.86	863.66	692.07
Profit Before Tax	529.30	-1376.58	-546.46	131.81	3490.25
Tax	201.96	-153.57	-244.99	-26.40	1243.74
Net Profit	409.55	-1211.59	-358.69	232.19	1772.85

Balance Sheet

In Rs. Cr.	202203	202303	202403	202503	202603
Assets+	14865.68	14837.61	15310.53	40198.24	45450.22
Liabilities+	14865.68	14837.61	15310.53	40198.24	45450.22

Peer Comparison

Consolidated

Peer comparison with financial metrics
company Name	market Cap	price	roa	roe	ebit Margin	pat Margin	reported Eps	adjusted Eps	dps	current Ratio	quick Ratio	total Debt Equity	interest Cover	asset Turnover	price Earnings Ratio	price Cash Earnings	price To Book	ev To Ebitda	dividend Yield
SUNPHARMA	439,726.12 Cr	1832.70	12.02	14.85	26.44	19.78	47.84	47.84	16.00	2.82	2.31	0.05	45.61	0.61	36.73	29.07	6.61	28.84	0.74
DIVISLAB	135,286.77 Cr	5096.15	13.31	16.19	32.46	24.43	96.91	96.91	30.00	4.12	2.76	0	142.17	0.54	61.36	51.99	9.66	49.36	0.59
CIPLA	133,392.75 Cr	1651.80	9.88	11.83	13.53	9.92	48.02	48.02	13.00	3.44	2.50	0.01	97.04	1.00	25.47	19.45	4.80	18.23	0.79
TORNTPHARM	117,159.66 Cr	3461.70	7.37	26.76	16.55	10.86	63.92	63.92	38.00	1.13	0.75	1.76	8.46	0.68	66.03	43.86	16.02	34.08	0.81
ZYDUSLIFE	113,503.19 Cr	1128.00	11.81	19.69	13.66	9.73	50.10	50.10	1.00	1.27	0.91	0.43	16.09	1.21	17.39	13.62	5.33	18.04	0.27
DRREDDY	113,241.24 Cr	6786.20	8.03	11.69	17.11	12.34	50.25	50.25	8.00	1.79	1.34	0.20	15.43	0.65	24.97	16.85	3.84	12.74	0.59
LUPIN	103,864.77 Cr	2277.05	16.12	27.11	16.95	12.42	116.64	116.64	18.00	1.90	1.42	0.26	16.82	1.30	19.83	15.71	6.93	24.16	0.35
MANKIND	96,647.39 Cr	2412.30	7.00	12.69	19.93	12.98	46.34	46.34	1.00	1.07	0.74	0.37	4.62	0.54	43.29	29.32	9.78	33.15	0
AUROPHARMA	90,814.63 Cr	1549.90	6.64	9.93	7.91	5.04	60.34	60.34	4.00	1.81	1.15	0.20	14.31	1.32	21.60	14.33	2.95	13.03	0.29
ALKEM	74,239.1 Cr	6209.10	13.44	18.29	13.43	10.43	192.54	192.54	53.00	2.55	1.86	0.12	18.86	1.29	27.54	23.18	6.85	26.10	0.64

Scroll horizontally to see more columns

Ratios

Reported EPS

Bad: 2Current: 4.06Good: 5

🟡

Adjusted EPS

Bad: 3Current: 4.06Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 13.10Good: 20

🟡

Current Ratio

Bad: 1Current: 2.38Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 9.06Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 9.59Good: 0.5

❌

Scroll vertically to see more ratios

Reported EPS

Bad: 2Current: 4.06Good: 5

🟡

Adjusted EPS

Bad: 3Current: 4.06Good: 6

🟡

Return On Capital Employed (ROCE)

Bad: 10Current: 13.10Good: 20

🟡

Current Ratio

Bad: 1Current: 2.38Good: 2

✅

Return On Equity (ROE)

Bad: 5Current: 9.06Good: 15

🟡

Debt to Total Assets

Bad: 1Current: 9.59Good: 0.5

❌

* Each ratio is marked as Good (✅), Average (🟡), or Bad (❌) based on its value.

Shareholder Pattern

In %	JUN'26	MAR'26	DEC'25	SEP'25	JUN'25	MAR'25	DEC'24	SEP'24	JUN'24	MAR'24
Promoters+	61.31	61.31	61.41	52.33	52.61	52.61	52.61	52.76	52.78	52.79
Public+	38.69	38.69	38.59	47.67	47.39	47.39	47.39	47.24	47.22	47.21
Custodians	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Number of Shareholders	128367	127446	134194	144085	147320	158152	162574	154603	163693	166593

Events:

* Data is updated every day around 8pm. During market hours, the chart shows the previous day's last value as the latest data point.

Viyash Scientific Ltd.

₹257

- 3.90 (-1.49%)

04:01 pm - close price

BSE: VIYASH

NSE: VIYASH

Industry: Pharmaceuticals & Drugs

House: Sequent

Overview

Corporate Actions

253 events in the last 3 years